Biological sector analysts suggest sgmo stock price could benefit from the biotech rebound predicted for Q3, assuming risk-off sentiment in equities eases. Historical beta for SGMO indicates higher volatility compared to peers. But note: Sangamo Therapeutics may not be the best stock to buy . So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Sangamo Therapeutics, Inc. (SGMO) : Free Stock Analysis Report Economic indicators like CPI and biotech funding trends are acting as macro bellwethers for sgmo stock price, influencing speculative flows and sentiment shifts among retail investors.
